Clinical Trial

Genes Associated With Bone Metabolism in the Saliva During Orthodontic Treatment

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Understanding the biological events during fixed orthodontic treatment is essential for optimizing treatment strategies, predicting patient response, and minimizing adverse effects. Most studies on bone remodeling have used invasive sampling methods such as tissue biopsies or serum collection; these methods cannot be used for routine clinical monitoring. Saliva is a simple medium that can reflect changes in local periodontal and bone conditions, it is also non-invasive and cheap. There is little evidence about the temporal expression of genes related to bone metabolism (RANKL, OPG, ALP, TRAP, RUNX2) in saliva during orthodontic therapy. This study will help advance the understanding of biological responses during orthodontic tooth movement and explore whether saliva can be an appropriate diagnostic medium for monitoring bone remodeling in orthodontic patients
Trial Details
NCT Number NCT07303647
Lead Sponsor Kurdistan Higher Council of Medical Specialties
Conditions Gene Expression Profiling, Orthodentic Appliances
Enrollment 24 participants
Start Date 2025-10-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-26